Literature DB >> 10852738

Type 1 cytokines and the pathogenesis of tuberculosis.

P F Barnes, B Wizel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10852738     DOI： 10.1164/ajrccm.161.6.16167

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  7 in total

1.  The relationship between diabetes and tuberculosis in Saskatchewan: comparison of registered Indians and other Saskatchewan people.

Authors:  Roland F Dyck; Helena Klomp; Darcy D Marciniuk; Leonard Tan; Mary Rose Stang; Heather A Ward; Vernon H Hoeppner
Journal:  Can J Public Health       Date:  2007 Jan-Feb

2.  Enhanced antimycobacterial response to recombinant Mycobacterium bovis BCG expressing latency-associated peptide.

Authors:  B G Marshall; A Wangoo; P O'Gaora; H T Cook; R J Shaw; D B Young
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

3.  Elevated Neopterin Levels Are Associated with Increased Tuberculosis Risk in Rheumatoid Arthritis Patients with QuantiFERON Conversion during Biologic Therapy.

Authors:  Der-Yuan Chen; Ju-Pi Li; Yi-Ming Chen; Tsai-Ling Liao; Hsin-Hua Chen; Chia-Wei Hsieh; Yea-Wen Yeh; Joung-Liang Lan
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

4.  An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable Diseases.

Authors:  Aftab Alam; Hala Abubaker Bagabir; Armiya Sultan; Mohd Faizan Siddiqui; Nikhat Imam; Mustfa F Alkhanani; Ahmad Alsulimani; Shafiul Haque; Romana Ishrat
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

5.  The Soluble Plasminogen Activator Receptor as a Biomarker on Monitoring the Therapy Progress of Pulmonary TB-AFB(+) Patients.

Authors:  Tri Yudani Mardining Raras; Iin Noor Chozin
Journal:  Tuberc Res Treat       Date:  2010-10-04

6.  Identification of a predominant isolate of Mycobacterium tuberculosis using molecular and clinical epidemiology tools and in vitro cytokine responses.

Authors:  M Kaushal Sharma; A Al-Azem; J Wolfe; E Hershfield; A Kabani
Journal:  BMC Infect Dis       Date:  2003-04-08       Impact factor: 3.090

7.  The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.

Authors:  Chong Hong Lim; Hsin-Hua Chen; Yi-Hsing Chen; Der-Yuan Chen; Wen-Nan Huang; Jaw-Ji Tsai; Tsu-Yi Hsieh; Chia-Wei Hsieh; Wei-Ting Hung; Ching-Tsai Lin; Kuo-Lung Lai; Kuo-Tung Tang; Chih-Wei Tseng; Yi-Ming Chen
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.